Production (Stage)
Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.86% | -33.94% | -6.35% | -15.88% | 285.74% |
| Total Receivables | 19.90% | -0.19% | 4.84% | 19.84% | 16.56% |
| Inventory | 32.45% | -5.78% | -47.53% | 3.88% | -4.27% |
| Prepaid Expenses | -20.65% | 0.46% | -29.98% | -2.43% | 74.29% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 115.45% | -14.65% | 92.93% | 75.78% | 265.91% |
| Total Current Assets | -2.60% | -23.88% | -6.77% | -8.80% | 153.82% |
|
|
|||||
| Total Current Assets | -2.60% | -23.88% | -6.77% | -8.80% | 153.82% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 317.03% | -14.02% | -3.34% | -3.23% | 16,933.33% |
| Total Assets | 3.24% | -23.72% | -6.71% | -8.72% | 157.57% |
|
|
|||||
| Total Accounts Payable | 62.91% | -16.19% | -13.04% | -14.55% | 37.74% |
| Total Accrued Expenses | -17.07% | 3.47% | 9.05% | -30.37% | 16.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -71.43% | -41.67% | -29.41% | -19.05% |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | -1.59% | 0.00% | -- |
| Total Other Current Liabilities | 0.00% | 0.00% | -1.59% | 0.00% | -- |
| Total Current Liabilities | 20.99% | -6.94% | -4.05% | -21.22% | 30.23% |
|
|
|||||
| Total Current Liabilities | 20.99% | -6.94% | -4.05% | -21.22% | 30.23% |
| Long-Term Debt | 0.07% | -39.75% | 1.01% | 1.36% | 1.35% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -1.73% | 0.00% | 1,249,600.00% |
| Total Liabilities | 2.88% | -20.71% | -0.66% | -2.51% | 71.96% |
|
|
|||||
| Common Stock & APIC | 0.54% | 0.61% | 0.92% | 0.57% | 0.87% |
| Retained Earnings | -0.53% | -0.91% | -2.71% | -2.69% | 5.86% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -0.14% | -13.56% | -281.06% | -145.02% | 125.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.14% | -13.56% | -281.06% | -145.02% | 125.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.14% | -13.56% | -281.06% | -145.02% | 125.93% |
|
|
|||||